Cargando…
New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
Non-alcoholic fatty liver disease (NAFLD) has become a major chronic disease in contemporary society, affected by N6-methyladenosine (m6A) RNA methylation, one of the most common RNA modifications. Compared with healthy control, m6A RNA methyltransferase 3 (METTL3) and METTL14 increased, while Wilms...
Autores principales: | Cheng, Wenli, Li, Min, Zhang, Luyun, Zhou, Cheng, Yu, Susu, Peng, Xinyue, Zhang, Wenji, Zhang, Wenjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471244/ https://www.ncbi.nlm.nih.gov/pubmed/36120320 http://dx.doi.org/10.3389/fphar.2022.973116 |
Ejemplares similares
-
Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours
por: Xia, Zhelin, et al.
Publicado: (2022) -
circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion
por: Zhang, Yonggang, et al.
Publicado: (2021) -
Widespread occurrence of N(6)-methyladenosine in bacterial mRNA
por: Deng, Xin, et al.
Publicado: (2015) -
The Roles of N(6)-Methyladenosine in Human
Diseases
por: An, Shanshan, et al.
Publicado: (2019) -
The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
por: Chen, Zhaolin, et al.
Publicado: (2022)